𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor

✍ Scribed by Jim A. Turpin; Catherine A. Schaeffer; Ming Bu; Lisa Graham; Robert W. Buckheit Jr.; David Clanton; William G. Rice

Book ID
113259107
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
664 KB
Volume
29
Category
Article
ISSN
0166-3542

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Oltipraz, a novel inhibitor of human imm
Oltipraz, a novel inhibitor of human immunodeficiency virus type 1 (HIV-1) replication
✍ Hans J. Prochaska; Surendra J. Chavan; Penny Baron; Bruce Polsky πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 750 KB

Glutathione (GSH) levels are markedly depleted in patients infected with human immunodeficiency virus type 1 (HIV-1) and supplementation of media with high concentrations (5-20 mM) of lowmolecular weight thiols prevents HIV-1 replication in cultured cells. We were intrigued whether chemopreventive e

Secretory leukocyte protease inhibitor:
Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein
✍ Nancy R Shine; Susan C Wang; Krystyna Konopka; Elizabeth A Burks; Nejat DΓΌzgΓΌneş πŸ“‚ Article πŸ“… 2002 πŸ› Elsevier Science 🌐 English βš– 150 KB

The ability of the salivary protein, secretory leukocyte protease inhibitor (SLPI), to inhibit human immunodeficiency virus-1 (HIV-1) infection in vitro has been reported previously and has led to the suggestion that SLPI may be partially responsible for the low oral transmission rate of HIV-1. Howe